FDA Inspection 1244087 - Neurocrine Biosciences Inc - July 18, 2024

Record Details

This FDA Inspection record concerns Neurocrine Biosciences Inc, with an inspection on July 18, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Neurocrine Biosciences Inc
Inspection Date: July 18, 2024
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 5f403df1-ed51-4ca3-b2ed-f93a3ab8b1d4

Violation Codes1

21 CFR 314.80(b)

Full citation text and observation details available on the Dashboard.